Emily Debreto, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 146 Lake St N, Forest Lake, MN 55025 Phone: 651-464-5235 Fax: 763-230-1924 |
Wendy M Camp, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 146 Lake St N, Forest Lake, MN 55025 Phone: 651-464-8502 Fax: 651-464-8547 |
Mrs. Rita Lynn Scanlan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 604 Ne 1st St, Birchwood Health Care Center, Forest Lake, MN 55025 Phone: 651-464-5600 |
Patricia Woolfrey-flatten, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1467 Lake St S Ste 300, Forest Lake, MN 55025 Phone: 651-241-3840 |
Sharon Ahlswede, MOTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 146 Lake St N Ste 200, Forest Lake, MN 55025 Phone: 651-275-4706 Fax: 651-770-1180 |
News Archive
A recently released report by the National Center on Addiction and Substance Abuse at Columbia University suggests between 1992 and 2003, more Americans were abusing controlled prescription drugs than cocaine, hallucinogens, inhalants and heroin put together.
A consensus is building that air pollution can cause neurological diseases such as Alzheimer's disease and Parkinson's disease, but how fine, sooty particles cause problems in the brain is still an unanswered question.
In this Politico opinion piece, Brian Atwood and colleagues, all former USAID administrators in previous Democratic or Republican administrations and current advisers to the U.S. Global Leadership Coalition, write, "Over the last half-century, USAID has had an extraordinary record of accomplishment. Using less than one percent of the U.S. budget annually, the American people have demonstrated their deepest values through USAID programs, saving tens of millions of lives worldwide with immunization programs, oral rehydration therapy, treatment for HIV/AIDS and work on other diseases."
In the online March 2006 version of Cancer, Dr. Kawakami and associates report from the CaPSURE database that primary androgen deprivation therapy (PADT) is used in 14% of prostate cancer (CaP) patients with reasonable outcomes at approximately 5 years follow-up.
› Verified 7 days ago